Inscripta, Inc.

Inscripta, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Inscripta merged with Manus in April 2025 to establish a unique end-to-end platform for scalable development, biomanufacturing, and commercialization of bioalternative products. By combining Inscripta’s advanced whole-genome engineering technologies with Manus’ proven cell factory engineering platform, biomanufacturing expertise, and commercialization capabilities, the merged company – Manus – is uniquely positioned to deliver commercial momentum and scaled profitability in next-generation industrial biotechnology.

Company Details

Employees
34
Founded
-
Address
Boston, Ma, Us
Phone
(720) 759-4088
Email
pr****@****pta.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Manager jobs.
HQ
Boston, MA
Looking for a particular Inscripta, Inc. employee's phone or email?

Inscripta, Inc. Questions

News

Persistence through integration: Assessing the Manus-Inscripta merger, through the GTESI lens - Biofuels Digest

Persistence through integration: Assessing the Manus-Inscripta merger, through the GTESI lens Biofuels Digest

INSCRIPTA® ANNOUNCES BIOMANUFACTURING OF A RAPIDLY GROWING ANTI-AGING SKINCARE INGREDIENT - PR Newswire

INSCRIPTA® ANNOUNCES BIOMANUFACTURING OF A RAPIDLY GROWING ANTI-AGING SKINCARE INGREDIENT PR Newswire

Biomanufacturing Milestone: Inscripta’s GenoScaler™ Brings Eco-Friendly Skincare Ingredients to Market - SynBioBeta

Biomanufacturing Milestone: Inscripta’s GenoScaler™ Brings Eco-Friendly Skincare Ingredients to Market SynBioBeta

Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be - Forbes

Inscripta Is Reimagining What The Synthetic Biology Company Of The Future Will Be Forbes

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing - Business Wire

Inscripta Announces the First Commercial Shipment of Its Onyx™ Digital Genome Engineering Platform and Closes $150 Million in New Financing Business Wire

Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform - Fierce Biotech

Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform Fierce Biotech

Former Inscripta CEO Sri Kosaraju Elected to Hertz Foundation Board of Directors | Newswise - Newswise

Former Inscripta CEO Sri Kosaraju Elected to Hertz Foundation Board of Directors | Newswise Newswise

Inscripta Launches the World’s First Benchtop Platform for Digital Genome Engineering - SynBioBeta

Inscripta Launches the World’s First Benchtop Platform for Digital Genome Engineering SynBioBeta

Inscripta Acquires Former Illumina Team via Solana Biosciences to Commercialize Gene Editing Tools - AgFunderNews

Inscripta Acquires Former Illumina Team via Solana Biosciences to Commercialize Gene Editing Tools AgFunderNews

Expanding and understanding the CRISPR toolbox for Bacillus subtilis with MAD7 and dMAD7 - Wiley Online Library

Expanding and understanding the CRISPR toolbox for Bacillus subtilis with MAD7 and dMAD7 Wiley Online Library

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform - PR Newswire

Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx™ Genome Engineering Platform PR Newswire

With $125M More in Financing, Inscripta Ramps Up Expansion - Genetic Engineering and Biotechnology News

With $125M More in Financing, Inscripta Ramps Up Expansion Genetic Engineering and Biotechnology News

Inscripta gets to next series C scene - - Global Venturing

Inscripta gets to next series C scene - Global Venturing

Inscripta bags $55M+ to push forward full CRISPR suite - Fierce Biotech

Inscripta bags $55M+ to push forward full CRISPR suite Fierce Biotech

INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING - PR Newswire

INSCRIPTA® ACQUIRES INFINOME BIOSCIENCES AND SESTINA BIO TO ADVANCE SUSTAINABLE BIOMANUFACTURING PR Newswire

Inscripta Appoints Sri Kosaraju as President and CEO - SynBioBeta

Inscripta Appoints Sri Kosaraju as President and CEO SynBioBeta

SESTINA BIO USES INSCRIPTA'S ONYX® PLATFORM TO DEVELOP MICROBIAL STRAIN READY FOR SCALE-UP IN LESS THAN 12 MONTHS - PR Newswire

SESTINA BIO USES INSCRIPTA'S ONYX® PLATFORM TO DEVELOP MICROBIAL STRAIN READY FOR SCALE-UP IN LESS THAN 12 MONTHS PR Newswire

Inscripta Raises $55.5 Million to Advance Gene-Editing Technology - PR Newswire

Inscripta Raises $55.5 Million to Advance Gene-Editing Technology PR Newswire

BEDOUKIAN RESEARCH INC. PARTNERS WITH INSCRIPTA TO SUSTAINABLY DEVELOP AND MANUFACTURE NATURALLY PRODUCED INGREDIENTS - PR Newswire

BEDOUKIAN RESEARCH INC. PARTNERS WITH INSCRIPTA TO SUSTAINABLY DEVELOP AND MANUFACTURE NATURALLY PRODUCED INGREDIENTS PR Newswire

Inscripta Granted Patents for CRISPR Gene-Editing Systems - PR Newswire

Inscripta Granted Patents for CRISPR Gene-Editing Systems PR Newswire

Writing in the Language of DNA: Kevin Ness on The Long Run - Timmerman Report

Writing in the Language of DNA: Kevin Ness on The Long Run Timmerman Report

Gene-editing company shutters Boulder headquarters - The Business Journals

Gene-editing company shutters Boulder headquarters The Business Journals

CRISPR Startup Inscripta Raises $55.5m Series C to Democratize Gene-Editing - AgFunderNews

CRISPR Startup Inscripta Raises $55.5m Series C to Democratize Gene-Editing AgFunderNews

Inscripta engineers $30m series C extension - - Global Venturing

Inscripta engineers $30m series C extension - Global Venturing

Sri Kosaraju, Former CEO of Inscripta, Joins Hertz Foundation Board of Directors - Bioengineer.org

Sri Kosaraju, Former CEO of Inscripta, Joins Hertz Foundation Board of Directors Bioengineer.org

Boulder Biotech Changes Name, Gives Away New CRISPR Enzyme -- Free of Charge - BioSpace

Boulder Biotech Changes Name, Gives Away New CRISPR Enzyme -- Free of Charge BioSpace

How The Skincare Industry Is Turning to Gene Editing in a Race Against Time - Forbes

How The Skincare Industry Is Turning to Gene Editing in a Race Against Time Forbes

Inscripta ropes in Sri Kosaraju as President and CEO - Tech Observer Magazine

Inscripta ropes in Sri Kosaraju as President and CEO Tech Observer Magazine

Boulder biotech company Inscripta raises $125M Series D funding - The Business Journals

Boulder biotech company Inscripta raises $125M Series D funding The Business Journals

Greek scholar to discuss opposing views of human mind - UMSL Blogs

Greek scholar to discuss opposing views of human mind UMSL Blogs

Top Inscripta, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant